Christopher E. Wolter, MD, presented “Counterpoint: Robotic Uterosacral Ligament Suspension” during the 31st Annual Perspectives in Urology: Point-Counterpoint, on October 18, 2024, in Scottsdale, Arizona.
How to cite: Wolter, Christopher E. “Counterpoint: Robotic Uterosacral Ligament Suspension.” October 18, 2024. Accessed Mar 2026. https://grandroundsinurology.com/counterpoint-robotic-uterosacral-ligament-suspension/
Counterpoint: Robotic Uterosacral Ligament Suspension – Summary
Christopher E. Wolter, MD, debates the merits of robotic uterosacral ligament suspension versus robotic sacrocolpopexy for pelvic organ prolapse repair. In this 11-minute presentation, he acknowledges the efficacy and durability of robotic sacrocolpopexy, while highlighting the emerging role of robotic uterosacral ligament suspension as a viable alternative.
Wolter explains the technical aspects of robotic uterosacral ligament suspension, emphasizing its comparable success rates, reduced operative times, and decreased risk of mesh-related complications. He outlines the surgical advantages of robotic techniques, including superior visualization and the ability to perform precise, high-apex suturing, which reduces ureteral injury risk.
Through comparative analyses, he illustrates that robotic uterosacral ligament suspension demonstrates equivalent quality-of-life improvements and subjective outcomes while offering better preservation of urinary function and lower urgency symptoms than sacrocolpopexy. He concludes that uterosacral ligament suspension is a safer option for high-risk patients and a valuable addition to the surgical repertoire for individualized care.
About the 31st Annual Perspectives in Urology: Point Counterpoint conference: Presented by Program Chair and Grand Rounds in Urology Editor-in-Chief E. David Crawford, MD, this conference brought together leading experts in urology, medical oncology, and radiation oncology to discuss and debate the latest topics in genitourinary cancers, primarily prostate cancer and bladder cancer. This interactive conference offered topical lectures, pro/con debates, interesting-case presentations, interactive panel discussions, and interactive audience and faculty networking.
ABOUT THE AUTHOR
Christopher E. Wolter, MD, is an Assistant Professor of Urology at the Mayo Clinic in Phoenix, Arizona. Dr. Wolter also serves as the Assistant Program Director for the Urology Residency Program and a member of the Surgical Quality Subcommittee at the Mayo Clinic Hospital. He specializes in urinary incontinence, pelvic organ prolapse, urologic reconstruction, urologic prosthetics, post-prostate cancer survivorship, erectile dysfunction, neurourology and neuromodulation, and overall functional considerations of urogenital health.
Dr. Wolter earned his medical degree from the University of Illinois in Rockford. He completed an internship in Surgery and a residency in Urology at Tulane University in Louisiana. Dr. Wolter then completed a residency in Urology and fellowships in Female Urology and Urodynamics & Reconstructive Urology at Vanderbilt University in Nashville, Tennessee.
Dr. Wolter has also served as the Director of Urologic Education for the preclinical and clinical rotations for the Mayo Clinic Alix School of Medicine in Phoenix. He is a member of the Society of Urodynamics, the American Urological Association, and the Mortality Review Subcommittee of the Arizona Quality & Process Improvement Committee. Dr. Wolter has published 64 articles and book chapters in his field.
